What to Know About Xolair and Food Allergies
The drug does not completely prevent reactions, but it can reduce the risks posed by trace amounts of food allergens. (Source: NYT Health)
Source: NYT Health - February 25, 2024 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Allergies Food Children and Childhood Drugs (Pharmaceuticals) Immune System Clinical Trials Research Health Insurance and Managed Care Source Type: news
An Asthma Drug Can Drastically Reduce Food Allergies
About 20 million people in the U.S.—including four million children—have food allergies. Now, there’s a new way to reduce their risk of severe allergic reactions. A study published in the New England Journal of Medicine reports that the drug omalizumab, or Xolair, allows people with food allergies to tolerate higher doses of allergenic foods before developing a reaction after an accidental exposure. It also leads to milder reactions if they are exposed.
[time-brightcove not-tgx=”true”]
The drug was originally approved more than two decades ago to treat allergic asthma. But because of this ...
Source: TIME: Health - February 25, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Omalizumab Limits Dangerous Reactions To Allergy Triggering Food
Study finds a drug that binds to allergy-causing antibodies can protect children from dangerous reactions to accidentally eating allergy-triggering foods (Source: Disabled World)
Source: Disabled World - February 25, 2024 Category: Disability Tags: Food Allergies Source Type: news
Antibody reduces allergic reactions to multiple foods in NIH clinical trial
Drug can help protect kids with multiple food allergies during accidental exposure. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - February 23, 2024 Category: American Health Source Type: news
Groundbreaking Food Allergy Treatment Research to Be Unveiled at 2024 American Academy of Allergy, Asthma & amp; Immunology Annual Meeting
Media Advisory for Late Breaking Symposium at the 2024 AAAAI Annual Meeting MILWAUKEE, Feb. 19, 2024 /PRNewswire-PRWeb/ -- Renowned allergist Dr. Robert A. Wood, MD FAAAAI, will present detailed findings from a Phase 3 clinical trial that will have significant impact in the world of food... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 19, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
New FDA-approved drug makes severe food allergies less life-threatening
Living with food allergies can be a fraught existence. There is no cure, and the standard management is to be ever vigilant of everything you eat and have an emergency shot of epinephrine constantly handy in case an accidental ingestion leads to a swift, life-threatening reaction. But, for the…#xolair #kellystone #criticalcare #fda (Source: Reuters: Health)
Source: Reuters: Health - February 17, 2024 Category: Consumer Health News Source Type: news
Expanded Use of Xolair to Treat Food Allergies Approved by the FDA
FRIDAY, Feb. 16, 2024 -- The U.S. Food and Drug Administration has expanded the use of the asthma drug Xolair (omalizumab) to help prevent anaphylactic reactions.Xolair is an injected drug and is not meant as a substitute for EpiPens or other... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 17, 2024 Category: Pharmaceuticals Source Type: news
FDA Approves Drug to Reduce Accidental Food Allergies FDA Approves Drug to Reduce Accidental Food Allergies
The new indication makes Xolair (omalizumab) the first drug approved to mitigate allergic reactions to more than one food.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 16, 2024 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology Source Type: news
FDA Expands Use of Asthma Med Xolair to Treat Food Allergies
FRIDAY, Feb. 16, 2024 -- People threatened by accidental exposure to foods they ' re allergic to may have a new weapon of defense: On Friday, the U.S. Food and Drug Administration expanded the use of the asthma drug Xolair to help prevent... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 16, 2024 Category: General Medicine Source Type: news
FDA Approves Xolair as First and Only Medicine for Children and Adults With One or More Food Allergies
South San Francisco, CA -- February 16, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair® (omalizumab) for the reduction of allergic... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 16, 2024 Category: Drugs & Pharmacology Source Type: news
FDA expands use of asthma drug Xolair to treat severe food allergies
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions (Source: ABC News: Health)
Source: ABC News: Health - February 16, 2024 Category: Consumer Health News Tags: Health Source Type: news
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2 Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Investor Update - February 16, 2024 Category: Pharmaceuticals Source Type: news
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2 Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Media News - February 16, 2024 Category: Pharmaceuticals Source Type: news
Uber makes changes to Super Bowl ad after backlash
Uber Eats has made last minute changes to its Super Bowl advertisement after criticism that it inappropriately made light of food allergies. The Food Allergy Research & Education (FARE) charity thanked the food delivery firm for agreeing to edit out parts that showed a man having an allergic…#ubereats #superbowl #fare #jenniferanniston #friendscostar #davidschwimmer #victoriabeckham #mspoblete (Source: Reuters: Health)
Source: Reuters: Health - February 11, 2024 Category: Consumer Health News Source Type: news
Does the QoL Impact of Food Allergies Affect Girls, Women More?
(MedPage Today) -- Sex or gender may play a role in how food allergies impact a patient's health-related quality of life (QoL), a systematic review of dozens of studies suggested.
Strong evidence from non-interventional studies indicated that... (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - February 8, 2024 Category: Pediatrics Source Type: news
